Navigation Links
Review of Nexavar Data Presented at ASCO 2007- Investor Conference,Call on June 4, 2007

Leverkusen, Germany, May 31, 2007- Results from various clinical studies including a pivotal Phase III trial in patients with advanced hepatocellular carcinoma, or primary liver cancer with Nexavar (sorafenib) tablets will be presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, USA from June 1 - 5, 2007.

On this occasion a conference call for investors and analysts will be held on June 4, 2007. Starting at around 2:00 p.m. CEST (12:00 noon GMT) live on the Internet, Bayer AG will be broadcasting the speech and discussion of the Investor Conference Call.

A recording of the conference call will be available as from 6:30 p.m. CEST (4:30 p.m. GMT).

The audio transmission and recording can be accessed on these sites:

English: http://www.investor.bayer.com German: http://www.investor.bayer.de

Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com

If you have any questions, please contact:

Dr. Alexander Rosar (+49-214-30-81013) Dr. Juergen Beunink (+49-214-30-65742) Peter Dahlhoff (+49-214-30-33022) Ilia Kürten (+49-214-30-35426) Ute Menke (+49-214-30-33021) Judith Nestmann (+49-214-30-66836) Dr. Olaf Weber (+49-214-30-33567)


'"/>




Page: 1

Related medicine technology :

1. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
2. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
3. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
4. Medicures MEND-CABG Trial Results Published in Peer Reviewed Journal
5. Reatas Synthetic Triterpenoids Profiled in Nature Reviews Cancer
6. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
7. Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified which Prevent Clear Interpretation of Results
8. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... -- It,s time for an upgrade. There are many medical recorders on the market but ... illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a renowned authorized ... of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... , May 4, 2016 According ... Development, Growth and Demand Forecast to 2022 - Industry Insights ... (Hospital, Diagnostic Center and Others)" by P&S Market Research, the ... million in 2015, and it is expected to grow at ... the high slice type segment is expected to witness the ...
(Date:5/4/2016)... , May 4, 2016 ... companies concluded a series of free workshops across ... global requirements for Good Distribution Practices ... quality assurance which ensures that products are consistently stored, transported ... marketing authorization (MA) or product specification. Only a few ...
Breaking Medicine Technology:
(Date:5/4/2016)... Gilmer, TX (PRWEB) , ... May 04, 2016 ... ... commencement of a master charity program created to assist the people of their ... working closely with nonprofit organizations and community leaders. Their hope is to bring ...
(Date:5/4/2016)... ... May 04, 2016 , ... May kicked off with Melanoma Monday , ... Dermatologist Dr. Ellen Turner is encouraging her patients, as well as residents all around ... safety and health now and in the future. , The dermatology-specific awareness month ends ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Dr. ... offering wisdom tooth removal surgery at their office. Wisdom tooth removal, a common dental ... not always problematic, they often are improperly erupted, resulting in risks of complications. By ...
(Date:5/4/2016)... ... 2016 , ... Nordic Naturals announces another breakthrough innovation—Omega Curcumin, ... synergistic combination of omega-3 fatty acids and potent antioxidants contains 1000 mg concentrated ... and 200 mg of N-Acetylcysteine (NAC). , Each nutrient plays a distinct ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Francesca Loparco, Co-Founder ... her life forever with a same-day LASIK procedure at Christenbury Eye Center. ... Dr. Jonathan Christenbury performed her surgery the same day as her in-office consultation and ...
Breaking Medicine News(10 mins):